Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
Carriers with T alleles were at a significantly decreased risk of developing EOC.
»
08/30/16
Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC.
Expression of A type 3 was not observed in non-malignant lung tissues.
»
08/10/15
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Upregulation of the SLC2A1, SLC2A3, and SLC2A14 genes was associated with increased mortality.
»
02/17/16
Propofol inhibits the growth and survival of gastric cancer cells in vitro through the upregulation of ING3.
siING3 transfection reversed the effects of propofol on the biological behavior of gastric cancer cells.
»
05/04/16
Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.
Patients with hyperglycemia are less likely to achieve complete response after NACT.
»
06/17/16
Withaferin A and its potential role in glioblastoma (GBM).
Withaferin A has gained much attention as a possible anti-neoplastic agent.
»
03/18/16
Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
HS-1793 showed more potent anticancer effects in several aspects than resveratrol in HCT116 cells.
»
06/01/16
Expression of metallothionein 3 in ductal breast cancer.
mRNA expression of MT-3 in IDC was also lower than in non‑malignant breast tissue.
»
06/13/16
[Expression of PAK1 in bladder cancer and its influence on invasion of bladder cancer cells].
Overexpression of PAK1 in bladder cancer tissues may be an important feature of bladder cancer.
»
11/18/16
A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib.
Emergence of an ALK F1245C mutation in an advanced ALK+ NSCLC patient.
»
11/03/15
< Prev
Next >